Sfoglia per Rivista
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.
2007-01-01 BERNENGO MG; QUAGLINO P; COMESSATTI A; ORTONCELLI M; NOVELLI M; LISA F; FIERRO MT
Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma.
2001-01-01 Palumbo A; Giaccone L; Bertola A; Pregno P; Bringhen S; Rus C; Triolo S; Gallo E; Pileri A; Boccadoro M
M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia.
1992-01-01 ZACCARIA A ;MARTINELLI G ;BUZZI M ;ZUFFA E ;ZAMAGNI MD ;TESTONI N ;RUSSO D ;GUERRASIO A ;SAGLIO G ;TURA S
MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse.
1990-01-01 Tarella C; Gallo E; Ferrero D; Badoni R; Carlesso N; Caracciolo D; Pileri A.
MAKING THE RIGHT CHOICE: THE ROLE OF FITNESS STATUS IN THE MANAGEMENT OF FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL FITNESS STUDY)
2015-01-01 Scarfo, L; Quaresmini, G; Mauro, Fr; Orlandi, E; Reda, G; Laurenti, L; Coscia, M; Ambrosetti, A; Murru, R; Trentin, L; Guelill, A; Visco, C; Morabito, F; Frustaci, A; Ciolli, S; Rossini, F; Cuneo, A; Gozzetti, A; Scortechini, I; Pane, F; Zinzani, Pl; Ferrara, F; Mannina, D; Marasca, R; Pierri, I; Specchia, G; Chiarenza, A; Zallio, F; Molica, S; De Paoli, L; Torreggiani, A; Brugiatelli, M; Semenzato, G; Innocenti, I; Picardi, P; Pizzolo, G; Foa, R; Rambaldi, A; Ghia, P
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO)
2004-01-01 Barosi, G; Boccadoro, M; Cavo, M; Corradini, P; Marchetti, M; Massaia, M; Merlini, G; Tosi, P; Tura, S; Palumbo, A
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
2006-01-01 BAROSI G; CARELLA A; LAZZARINO M; MARCHETTI M; MARTELLI M; RAMBALDI A; TARELLA C; VITOLO U; ZINZANI PL; TURA S
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation
2005-01-01 BAROSI G; CARELLA A; LAZZARINO M; MARCHETTI M; MARTELLI M; RAMBALDI A; TARELLA C; VITOLO U; ZINZANI PL; TURA S
Marriage and parenthood among subjects cured of childhood cancer: a report from the Italian AIEOP Off-Therapy Registry
2011-01-01 Pivetta E; Maule MM; Pisani P; Zugna D; Haupt R; Jankovic M; Arico' M; Casale F; Clerico A; Cordero di Montezemolo L; Kiren V; Locatelli F; Palumbo G; Pession A; Pillon M; Santoro N; Terenziani M; Valsecchi MG; Dama E; Magnani C; Merletti F; Pastore G.
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway.
2014-01-01 P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia.
Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial
2010-01-01 Palumbo A, Larocca A, Genuardi M, Kotwica K, Gay F, Rossi D, Benevolo G, Magarotto V, Cavallo F, Bringhen S, Rus C, Masini L, Iacobelli M, Gaidano G, Mitsiades C, Anderson K, Boccadoro M, Richardson P; Italian Multiple Myeloma Network GIMEMA.
MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSO MELPHALAN (200 MG/M2) E TRAPIANTO AUTOLOGO (MEL200) IN PAZIENTI CON NUOVA DIAGNOSI DI MIELOMA MULTIPLO (MM): UNO STUDIO DI FASE III.
2011-01-01 Cavallo F; Lupo B; Di Raimondo F; Ben Yehuda D; Corradini P; Patriarca F; Cavo M; Carella AM; Omedè P; Stanevsky S;Siniscalchi A; Cavalli M; Marcatti M; Petrò D; Crippa C; Levi A; Caravita Di Toritto T; Nagler A; Boccadoro M; Palumbo A
MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSUS HIGHDOSEMELPHALAN AND AUTOLOGOUS TRANSPLANTATION (MEL200)IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS: APHASE III STUDY
2011-01-01 A Palumbo; F Cavallo; B Lupo; A Nagler; V Redoglia; M Cavalli; A Carella; A Cafro; F Patriarca; A Siniscalchi; F Rossini; C Crippa; P Corradini; M Cavo; S Grammatico; A Stanevsky; D Ben Yehuda; F Di Raimondo; T Caravita Di Toritto; M Boccadoro
Membrane-bound IL-15 stimulation on peripheral blood natural kiler progenitors leads to the generation of an adherent subset co-expressing dendritic cells and natural kiler functional markers
2011-01-01 Negrini S; Giuliani M; Durali D; Chouaib S; Azzarone B
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells
2008-01-01 Mareschi K; Rustichelli D; Ferrero I; Comunanza V; Fazio R; Saglio F; Martinoglio B; Medico E; Carbone E; Benedetto C; Fagioli F
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells
2007-01-01 Rustichelli D; Mareschi K; Ferrero I; Manetta T; De Fazio R; Anselmino A; Morterra G; Gunetti M; Comunanza V; Carbone E; Fagioli F
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL)
2008-01-01 M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia
Microsatellite analysis in childhood acute lymphoblastic leukemia
1998-01-01 Reato G; Basso G; Putti MC; Cignetti A; Guarini A; Foa R
Il Mieloma multiplo.
1991-01-01 Boccadoro M; Battaglio S; Dianzani U; Frieri R; Gallone G; Massaia M; Omedè P; Palumbo A; Pileri A
MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM
2013-01-01 Ladetto M.; Bruggeman M; Monitillo L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. | 2007 | BERNENGO MG; QUAGLINO P; COMESSATTI A; ORTONCELLI M; NOVELLI M; LISA F; FIERRO MT | |
| Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma. | 2001 | Palumbo A; Giaccone L; Bertola A; Pregno P; Bringhen S; Rus C; Triolo S; Gallo E; Pileri A; Boccadoro M | |
| M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia. | 1992 | ZACCARIA A ;MARTINELLI G ;BUZZI M ;ZUFFA E ;ZAMAGNI MD ;TESTONI N ;RUSSO D ;GUERRASIO A ;SAGLIO G ;TURA S | |
| MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse. | 1990 | Tarella C; Gallo E; Ferrero D; Badoni R; Carlesso N; Caracciolo D; Pileri A. | |
| MAKING THE RIGHT CHOICE: THE ROLE OF FITNESS STATUS IN THE MANAGEMENT OF FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL FITNESS STUDY) | 2015 | Scarfo, L; Quaresmini, G; Mauro, Fr; Orlandi, E; Reda, G; Laurenti, L; Coscia, M; Ambrosetti, A; Murru, R; Trentin, L; Guelill, A; Visco, C; Morabito, F; Frustaci, A; Ciolli, S; Rossini, F; Cuneo, A; Gozzetti, A; Scortechini, I; Pane, F; Zinzani, Pl; Ferrara, F; Mannina, D; Marasca, R; Pierri, I; Specchia, G; Chiarenza, A; Zallio, F; Molica, S; De Paoli, L; Torreggiani, A; Brugiatelli, M; Semenzato, G; Innocenti, I; Picardi, P; Pizzolo, G; Foa, R; Rambaldi, A; Ghia, P | |
| Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO) | 2004 | Barosi, G; Boccadoro, M; Cavo, M; Corradini, P; Marchetti, M; Massaia, M; Merlini, G; Tosi, P; Tura, S; Palumbo, A | |
| Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation | 2006 | BAROSI G; CARELLA A; LAZZARINO M; MARCHETTI M; MARTELLI M; RAMBALDI A; TARELLA C; VITOLO U; ZINZANI PL; TURA S | |
| Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation | 2005 | BAROSI G; CARELLA A; LAZZARINO M; MARCHETTI M; MARTELLI M; RAMBALDI A; TARELLA C; VITOLO U; ZINZANI PL; TURA S | |
| Marriage and parenthood among subjects cured of childhood cancer: a report from the Italian AIEOP Off-Therapy Registry | 2011 | Pivetta E; Maule MM; Pisani P; Zugna D; Haupt R; Jankovic M; Arico' M; Casale F; Clerico A; Cordero di Montezemolo L; Kiren V; Locatelli F; Palumbo G; Pession A; Pillon M; Santoro N; Terenziani M; Valsecchi MG; Dama E; Magnani C; Merletti F; Pastore G. | |
| Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. | 2014 | P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia. | |
| Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial | 2010 | Palumbo A, Larocca A, Genuardi M, Kotwica K, Gay F, Rossi D, Benevolo G, Magarotto V, Cavallo F, Bringhen S, Rus C, Masini L, Iacobelli M, Gaidano G, Mitsiades C, Anderson K, Boccadoro M, Richardson P; Italian Multiple Myeloma Network GIMEMA. | |
| MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSO MELPHALAN (200 MG/M2) E TRAPIANTO AUTOLOGO (MEL200) IN PAZIENTI CON NUOVA DIAGNOSI DI MIELOMA MULTIPLO (MM): UNO STUDIO DI FASE III. | 2011 | Cavallo F; Lupo B; Di Raimondo F; Ben Yehuda D; Corradini P; Patriarca F; Cavo M; Carella AM; Omedè P; Stanevsky S;Siniscalchi A; Cavalli M; Marcatti M; Petrò D; Crippa C; Levi A; Caravita Di Toritto T; Nagler A; Boccadoro M; Palumbo A | |
| MELPHALAN/PREDNISONE/LENALIDOMIDE (MPR) VERSUS HIGHDOSEMELPHALAN AND AUTOLOGOUS TRANSPLANTATION (MEL200)IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS: APHASE III STUDY | 2011 | A Palumbo; F Cavallo; B Lupo; A Nagler; V Redoglia; M Cavalli; A Carella; A Cafro; F Patriarca; A Siniscalchi; F Rossini; C Crippa; P Corradini; M Cavo; S Grammatico; A Stanevsky; D Ben Yehuda; F Di Raimondo; T Caravita Di Toritto; M Boccadoro | |
| Membrane-bound IL-15 stimulation on peripheral blood natural kiler progenitors leads to the generation of an adherent subset co-expressing dendritic cells and natural kiler functional markers | 2011 | Negrini S; Giuliani M; Durali D; Chouaib S; Azzarone B | |
| Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells | 2008 | Mareschi K; Rustichelli D; Ferrero I; Comunanza V; Fazio R; Saglio F; Martinoglio B; Medico E; Carbone E; Benedetto C; Fagioli F | |
| Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells | 2007 | Rustichelli D; Mareschi K; Ferrero I; Manetta T; De Fazio R; Anselmino A; Morterra G; Gunetti M; Comunanza V; Carbone E; Fagioli F | |
| The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) | 2008 | M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia | |
| Microsatellite analysis in childhood acute lymphoblastic leukemia | 1998 | Reato G; Basso G; Putti MC; Cignetti A; Guarini A; Foa R | |
| Il Mieloma multiplo. | 1991 | Boccadoro M; Battaglio S; Dianzani U; Frieri R; Gallone G; Massaia M; Omedè P; Palumbo A; Pileri A | |
| MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM | 2013 | Ladetto M.; Bruggeman M; Monitillo L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile